Internal Medicine, Endocrinology, Diabetes, & Metabolism · Metairie, LA
NPI
1104840404
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3939 Houma Blvd, Suite 216
Metairie, LA, 70006
Phone (504) 888-3292
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
822 services
Medicare patients, 2024
263
Average age 72
Drug cost, 2024
$2.1M
10,989 prescriptions
Company payments, 2025
$1,273
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Miguel P Rivera was code 99214 (office e&m - established), 451 times for 202 patients. In total Miguel P Rivera billed 822 services in 12 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 451 | 202 | $85.40 | $39K |
| 99232 Hospital E&M - Subsequent | Facility | 261 | 53 | $60.10 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 35 | 33 | $90.62 | $3,172 |
| 99204 Office E&M - New | Office | 21 | 21 | $126.24 | $2,651 |
By year: 2022 $69K for 958 services; 2023 $64K for 857 services; 2024 $63K for 822 services.
Medicare prescription drug claims, 2024
In 2024, the drug Miguel P Rivera prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,015 prescriptions and refills. In total Miguel P Rivera wrote 10,989 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,015 | 2,816 | 269 | $7,963 |
| Mounjaro Tirzepatide | 418 | 455 | 71 | $478K |
| Metformin Hcl Er Metformin Hcl | 391 | 1,032 | 122 | $3,137 |
| Ozempic Semaglutide | 312 | 429 | 59 | $412K |
| Rosuvastatin Calcium Generic | 286 | 777 | 91 | $3,103 |
| Alprazolam Generic | 274 | 280 | 44 | $1,108 |
| Glimepiride Generic | 246 | 691 | 74 | $2,236 |
| Synthroid Levothyroxine Sodium | 221 | 510 | 50 | $19K |
| Gabapentin Generic | 218 | 564 | 67 | $4,454 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 214 | 316 | 54 | $28K |
| Metformin Hcl Generic | 202 | 589 | 61 | $1,266 |
| Pravastatin Sodium Generic | 198 | 541 | 61 | $2,177 |
| Atorvastatin Calcium Generic | 187 | 521 | 64 | $1,614 |
| Amlodipine Besylate Generic | 187 | 505 | 57 | $729 |
| Losartan Potassium Generic | 175 | 493 | 54 | $1,631 |
Brand drugs: 2,982 claims; generic drugs: 7,598 claims; opioid claims: 273.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Miguel P Rivera $1,273 ($1,273 in general payments such as food, travel and fees) from 22 companies. The largest payer was Antares Pharma, Inc. with $180.
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 10 | $180 |
| Lilly USA, LLC LLY | 9 | $152 |
| Xeris Pharmaceuticals, Inc. | 11 | $146 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $95.48 |
| Insulet Corporation PODD | 4 | $91.44 |
| Corcept Therapeutics CORT | 4 | $84.01 |
| Beta Bionics, Inc. BBNX | 5 | $73.8 |
| Acella Pharmaceuticals, LLC | 3 | $54.45 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $48.14 |
| Azurity Pharmaceuticals, Inc. | 2 | $44.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.